Mucus-penetrating archaeolipid nanocarriers delivering Thymus vulgaris essential oil and tobramycin: A multifunctional approach against Pseudomonas aeruginosa biofilms and inflammation

This publication has 41 references indexed in Scilit:

• Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis‐Related Pseudomonas aeruginosa Biofilms
  Small, 2021
• Bacterioruberin from Haloarchaea plus dexamethasone in ultra-small macrophage-targeted nanoparticles as potential intestinal repairing agent
  Colloids and Surfaces B: Biointerfaces, 2020
• Anti‐inflammatories and mucociliary clearance therapies in the age of CFTR modulators
  Pediatric Pulmonology, 2019
• Stimulation of the class-A scavenger receptor induces neutrophil extracellular traps (NETs) by ERK dependent NOX2 and ROMO1 activation
  Biochemical and Biophysical Research Communications, 2019
• Inflammation in cystic fibrosis: An update
  Pediatric Pulmonology, 2018
• Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls
  European Journal of Pharmaceutics and Biopharmaceutics, 2018
• PEGylation for enhancing nanoparticle diffusion in mucus
  Advanced Drug Delivery Reviews, 2018
• The role of mucus on drug transport and its potential to affect therapeutic outcomes
  Advanced Drug Delivery Reviews, 2018
• NADPH oxidase derived reactive oxygen species are involved in human neutrophil IL‐1β secretion but not in inflammasome activation
  European Journal of Immunology, 2013
• A rapid and sensitive sub-micro phosphorus determination
  Analytica Chimica Acta, 1961